Single Technologies
Single’s 3D video microscope can deliver high resolution 3D images from 10,000 cells in a single second run without any visible bleaching.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
* | N/A | Early VC | |
| Total Funding | 000k | ||
| EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 45 % | 24 % | - | 39 % | 24 % | 10 % | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (36 %) | (53 %) | (36 %) | (28 %) | (42 %) | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (42 %) | (63 %) | (42 %) | (42 %) | (45 %) | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Dealroom estimates
Related Content
Single Technologies AB is a pioneering company in the field of DNA sequencing, offering high-throughput and low-cost solutions that make it feasible to read DNA in individual cells and in large quantities. The company serves clients involved in advanced genetic research, including initiatives like the Human Cell Atlas project and those utilizing DNA editing tools such as CRISPR Cas9. Operating in the biotechnology and genomics market, Single Technologies aims to decode the complex sequences of DNA to better understand and potentially improve life forms. The business model revolves around providing cutting-edge DNA sequencing technology to research institutions, pharmaceutical companies, and other entities focused on genetic research. Revenue is generated through the sale of sequencing services and related technologies. By enabling detailed mapping of DNA sequences and cellular organization, Single Technologies plays a crucial role in advancing our understanding of genetics and cellular biology.
Keywords: DNA sequencing, high-throughput, low-cost, individual cells, genetic research, Human Cell Atlas, CRISPR Cas9, biotechnology, genomics, cellular biology.